Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mesothelioma, Malignant 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Glioblastoma 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Gemcitabine 58130-nm albumin-bound paclitaxel 35Specimen Handling 26Fluorouracil 22Albumin-Bound Paclitaxel 22Magnetic Resonance Spectroscopy 21Leucovorin 21Irinotecan 21Oxaliplatin 19Biopsy 17Taxes 16pembrolizumab 15Cyclophosphamide 12Cisplatin 11fludarabine 10Cetuximab 9Capecitabine 8durvalumab 7Radiosurgery 7Nivolumab 7Carboplatin 7irinotecan sucrosofate 6dehydroftorafur 6Pemetrexed 6olaparib 5Radiotherapy 5Ipilimumab 5Erlotinib Hydrochloride 5Blood Specimen Collection 5trastuzumab deruxtecan 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neoplasms × Pharmaceutical Preparations × 90 days × Clear all
NCT07254091 2026-03-06

Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer

Northwell Health

Phase EARLY_PHASE1 Recruiting
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡